CD44 as a prognostic and predictive marker for GBM.
Authors:
- B. D. VaillantBVB. D. Vaillant
- K. BhatKBK. Bhat
- E. P. SulmanESE. P. Sulman
- V. BalasubramaniyanVBV. Balasubramaniyan
- S. WangSWS. Wang
- K. D. AldapeKAK. D. Aldape
- H. ColmanHCH. Colman
- 20 May 2011
- journal article
- central nervous-system-tumors
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (15_suppl) , 2049